Stanley Miller, the chemist whose landmark experiment published in 1953 showed how some of the molecules of life could have formed on a young Earth, left behind boxes of experimental samples that he never analyzed. The first-ever analysis of some of Miller’s old samples has revealed another way that important molecules could have formed on early Earth.

Paper Chemistry Foundation gift supports future of forest bioproducts research and education.

New research reveals how the algae behind red tide thoroughly disables – but doesn’t kill – other species of algae. The study shows how chemical signaling between algae can trigger big changes in the marine ecosystem.

Researchers at the Georgia Tech Research Institute are developing a micro gas chromatograph for early detection of diseases in crops. 

When making cellulosic ethanol from plants, one problem is what to do with a woody agricultural waste product called lignin. The old adage in the pulp industry has been that one can make anything from lignin except money.

New system provides security by monitoring how user touches the screen.

Researchers at the Georgia Institute of Technology and the Joint BioEnergy Institute have engineered a bacterium to synthesize pinene, a hydrocarbon produced by trees that could potentially replace high-energy fuels, such as JP-10, in missiles and other aerospace applications. With improvements in process efficiency, the biofuel could supplement limited supplies of petroleum-based JP-10, and might also facilitate development of a new generation of more powerful engines.

Proof-of-concept study could soon allow analysis of early earth chemistry on meteorites and other rocks.

Invention gives amputee more control and creativity

If a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient’s cancer treatment on commonly disrupted genes and pathways.